Nom du produit:7-tert-butyl-3-(2,5-difluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine

IUPAC Name:5-({[7-tert-butyl-3-(2,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]oxy}methyl)-1-methyl-1H-1,2,4-triazole

CAS:286456-42-6
Formule moléculaire:C19H19F2N7O
Pureté:95%+
Numéro de catalogue:CM338507
Poids moléculaire:399.41

Unité d'emballage Stock disponible Prix($) Quantité
CM338507-100mg 4-5 Weeks ȋœȋ
CM338507-250mg 5-6 Weeks ƏƏǠŭ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:286456-42-6
Formule moléculaire:C19H19F2N7O
Point de fusion:-
Code SMILES:CN1N=CN=C1COC2=NN3C(C=C2C(C)(C)C)=NN=C3C4=CC(F)=CC=C4F
Densité:
Numéro de catalogue:CM338507
Poids moléculaire:399.41
Point d'ébullition:
N° Mdl:MFCD08690609
Stockage:2-8°C

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Related Products